Total planned funding: $129,751,136
Allocations
Countries/Regions
India | $129,751,136 |
Organizational Types
Unknown | $83,557,899 |
NGO | $19,295,145 |
Own Agency | $18,481,284 |
University | $3,000,000 |
Multi-lateral Agency | $2,656,808 |
Private Contractor | $1,659,000 |
FBO | $1,100,000 |
Host Country Government Agency | $1,000 |
Other USG Agency | $0 |
Program Areas
Governance and Systems | $45,213,851 |
Prevention | $34,240,500 |
Care | $16,134,307 |
Management and Operations | $14,098,869 |
Testing | $8,058,357 |
Treatment | $7,577,460 |
Budget Codes
OHSS: Health Systems Strengthening | $23,800,769 |
HVSI: Strategic Information | $17,362,358 |
HVOP: Sexual Prevention: Other Sexual Prevention | $14,822,434 |
HVMS: Management and Operations | $14,098,869 |
HBHC: Care: Adult Care and Support | $11,901,162 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $9,199,290 |
HVCT: Testing: HIV Testing and Counseling | $8,058,357 |
HTXS: Treatment: Adult Treatment | $7,289,189 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $4,521,130 |
HLAB: Laboratory Infrastructure | $4,050,724 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $3,183,379 |
HMBL: Biomedical Prevention: Blood Safety | $2,514,267 |
HKID: Care: Orphans and Vulnerable Children | $2,435,560 |
HVTB: Care: TB/HIV | $1,797,585 |
PDTX: Treatment: Pediatric Treatment | $264,794 |
HTXD: Treatment: ARV Drugs | $23,477 |
Top Partner Programs
Not Available:
$83,557,899
Countries/Regions
FHI 360:
$13,287,057
Countries/Regions
USG Aggregated Agencies:
$10,790,832
Countries/Regions
University of Washington:
$3,000,000
Countries/Regions